Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myles Wolf

Showing results (131-140 of 308) with videos related to

Pageof 31
Sort By:
Journal of the American Society of Nephrology : JASN|February 25, 2005
Activated injectable vitamin D and hemodialysis survival: a historical cohort studyMing Teng, Myles Wolf, M Norma Ofsthun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2018
Genetic background influences cardiac phenotype in murine chronic kidney diseaseSamantha Neuburg, Corey Dussold, Claire Gerber, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2015
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort StudiesJingjing Da, Xinfang Xie, Myles Wolf, et al.
Journal of the American Society of Nephrology : JASN|July 10, 2025
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled TrialDaniel Edmonston, Tamara Isakova, Laura M Dember, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Transplantation|July 16, 2015
A Prospective Cohort Study of Mineral Metabolism After Kidney TransplantationMyles Wolf, Matthew R Weir, Nelson Kopyt, et al.
Kidney International Reports|May 5, 2018
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric OxideMasaaki Nakayama, Yoshihiro Tani, Wan-Jun Zhu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 6, 2012
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT studyMarkus Ketteler, Kevin J Martin, Myles Wolf, et al.
Kidney360|June 2, 2023
Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA CohortAshwin Sunderraj, Mandy Wong, Orlando M Gutiérrez, et al.
Archives of Internal Medicine|June 15, 2007
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination SurveyDavid Martins, Myles Wolf, Deyu Pan, et al.
Pageof 31

Showing results (131-140 of 308) with videos related to

Sort By:
Pageof 31
Journal of the American Society of Nephrology : JASN|February 25, 2005
Activated injectable vitamin D and hemodialysis survival: a historical cohort studyMing Teng, Myles Wolf, M Norma Ofsthun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2018
Genetic background influences cardiac phenotype in murine chronic kidney diseaseSamantha Neuburg, Corey Dussold, Claire Gerber, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2015
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort StudiesJingjing Da, Xinfang Xie, Myles Wolf, et al.
Journal of the American Society of Nephrology : JASN|July 10, 2025
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled TrialDaniel Edmonston, Tamara Isakova, Laura M Dember, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Transplantation|July 16, 2015
A Prospective Cohort Study of Mineral Metabolism After Kidney TransplantationMyles Wolf, Matthew R Weir, Nelson Kopyt, et al.
Kidney International Reports|May 5, 2018
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric OxideMasaaki Nakayama, Yoshihiro Tani, Wan-Jun Zhu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 6, 2012
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT studyMarkus Ketteler, Kevin J Martin, Myles Wolf, et al.
Kidney360|June 2, 2023
Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA CohortAshwin Sunderraj, Mandy Wong, Orlando M Gutiérrez, et al.
Archives of Internal Medicine|June 15, 2007
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination SurveyDavid Martins, Myles Wolf, Deyu Pan, et al.
Pageof 31